Responses
Poster Presentation
Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
